CRUK Commercial Partnerships acts as the meeting point between the charity's funded research and industry. It helps to accelerate the translation of research into products for patient benefit through the development and commercialisation of exciting new discoveries. In addition, any revenue received through its commercial partnerships is reinvested back into developing lifesaving research.

This annual review aims to demonstrate the commitment of Commercial Partnerships over the last year to the researchers whom it supports with achieving their translational ambitions, the companies with whom it partners and the cancer patients to whom its efforts are ultimately dedicated.

Over the last financial year, Commercial Partnerships supported CRUK researchers to learn entrepreneurial skills, file 38 patents, create two spinout companies and re-invested £43 million back into cancer research. This includes scientists at the Beatson (page 23 of report).

Read the full report pdf  CRUK CP Annual Review 2019/20 (10.57 MB)